Frontlight ResearchEarly access
Trial site
Instytut Diabetologii.sp.z.o.o.
- 6running trials
- 7closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Obesity6 trials
- Type 1 diabetes5 trials
- Type 2 diabetes5 trials
- Phase
- Phase 311 trials
- Phase 22 trials
- Status
- Completed7 trials
- Active, not recruiting4 trials
- Recruiting2 trials
- Lead sponsor
- Eli Lilly and Company3 trials
- Novo Nordisk A/S3 trials
- Pfizer2 trials
- Diamyd Medical AB1 trial
- Merck Sharp & Dohme LLC1 trial
- and 3 more
Running trials
Active, not recruiting
Active, not recruiting
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Completed
Active, not recruiting
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
Completed
Active, not recruiting
Completed
Completed
Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)
Site data: ClinicalTrials.govUpdated 18 Nov 2026